Company intelligence / Profile preview

ISDIN

Barcelona, Catalonia, Spainisdin.com ↗

Ownership: Private
Employees: ~1700
Development stage: Commercial

Overview

ISDIN’s products are widely used globally with clinical studies supporting efficacy for several lines. Their Eryfotona Actinica sunscreen contains photolyase enzyme to aid DNA repair post-sun exposure. The Isdinceutics line includes clinically tested anti-aging serums and targeted solutions for pigmentation and eye area concerns. U.S.-specific clinical data are being developed; European product studies are available.

Therapeutic areas: Dermatology
Modalities: Small moleculeBiologic (for topical and dermatological use)Device (cosmetic/dermatological devices)
Industry: Non-Drug Biotech

Partnerships

Works closely with dermatologists and pharmacists worldwidemember of various industry associations including Farma Industria Asociación Nacional Empresarial de la Industria Farmaceutica

Beyond the preview

Go deeper on ISDIN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISDIN.

Explore the full profile